Home > Insider Trading > Filing (0001628280-24-050224)

Filing Details

Accession Number:: 0001628280-24-050224
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-12-06 16:20:40
Reporting Period:: 2024-12-04

Accepted Time:: 2024-12-06 16:20:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1588978	Procept Biorobotics Corp	PRCT	Surgical & Medical Instruments & Apparatus (3841)	260199180

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1632326	Reza Zadno	C/O Procept Biorobotics Corporation 150 Baytech Drive San Jose CA 95134	President, Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-12-04	5,300	$96.15	173,885	No	4	S	Direct
Common Stock	Disposition	2024-12-04	13,762	$97.01	160,123	No	4	S	Direct
Common Stock	Disposition	2024-12-04	5,126	$98.09	154,997	No	4	S	Direct
Common Stock	Disposition	2024-12-04	2,235	$99.04	152,762	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.65 to $96.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.65 to $97.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.66 to $98.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.97 to $99.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.